{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T09:48:22Z","timestamp":1782899302142,"version":"3.54.5"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T00:00:00Z","timestamp":1755734400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T00:00:00Z","timestamp":1755734400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Science and Technology Program of Yunnan Provincial Science and Technology Department","award":["202201AY070001-145 and 202201AY070001-149"],"award-info":[{"award-number":["202201AY070001-145 and 202201AY070001-149"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Colorectal Dis"],"DOI":"10.1007\/s00384-025-04987-7","type":"journal-article","created":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T23:11:20Z","timestamp":1755731480000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["ERO1\u03b1 regulates colon cancer progression and 5-FU resistance through the miR-451a\/ARF1 axis"],"prefix":"10.1007","volume":"40","author":[{"given":"Kun","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhua","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Lian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenliang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,21]]},"reference":[{"issue":"2","key":"4987_CR1","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.critrevonc.2010.01.010","volume":"74","author":"R Labianca","year":"2010","unstructured":"Labianca R, Beretta GD, Kildani B et al (2010) Colon cancer. Crit Rev Oncol Hematol 74(2):106\u2013133","journal-title":"Crit Rev Oncol Hematol"},{"issue":"1","key":"4987_CR2","first-page":"7","volume":"68","author":"RL Siegel","year":"2018","unstructured":"Siegel RL, Miller KD, Jemal A (2018) Cancer statistics, 2018. CA Cancer J Clin 68(1):7\u201330","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"4987_CR3","first-page":"409","volume":"72","author":"KD Miller","year":"2022","unstructured":"Miller KD, Nogueira L, Devasia T et al (2022) Cancer treatment and survivorship statistics, 2022. CA Cancer J Clin 72(5):409\u2013436","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"4987_CR4","doi-asserted-by":"publisher","first-page":"412","DOI":"10.6004\/jnccn.2018.0020","volume":"16","author":"DE Wood","year":"2018","unstructured":"Wood DE, Kazerooni EA, Baum SL et al (2018) Lung cancer screening, version 3.2018, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw 16(4):412\u2013441","journal-title":"J Natl Compr Canc Netw"},{"issue":"1","key":"4987_CR5","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12951-019-0563-2","volume":"18","author":"G Liang","year":"2020","unstructured":"Liang G, Zhu Y, Ali DJ et al (2020) Engineered exosomes for targeted co-delivery of miR-21 inhibitor and chemotherapeutics to reverse drug resistance in colon cancer. J Nanobiotechnology 18(1):10","journal-title":"J Nanobiotechnology"},{"issue":"4","key":"4987_CR6","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/S0928-0987(00)00114-7","volume":"11","author":"R Krishna","year":"2000","unstructured":"Krishna R, Mayer LD (2000) Multidrug resistance (MDR) in cancer. Mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs. Eur J Pharm Sci 11(4):265\u2013283","journal-title":"Eur J Pharm Sci"},{"key":"4987_CR7","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1146\/annurev-pathol-012513-104649","volume":"10","author":"SA Oakes","year":"2015","unstructured":"Oakes SA, Papa FR (2015) The role of endoplasmic reticulum stress in human pathology. Annu Rev Pathol 10:173\u2013194","journal-title":"Annu Rev Pathol"},{"key":"4987_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.836087","volume":"12","author":"J Tao","year":"2022","unstructured":"Tao J, Yin L, Wu A et al (2022) PDIA2 bridges endoplasmic reticulum stress and metabolic reprogramming during malignant transformation of chronic colitis. Front Oncol 12:836087","journal-title":"Front Oncol"},{"key":"4987_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2021.114737","volume":"192","author":"D Liang","year":"2021","unstructured":"Liang D, Khoonkari M, Avril T et al (2021) The unfolded protein response as regulator of cancer stemness and differentiation: mechanisms and implications for cancer therapy. Biochem Pharmacol 192:114737","journal-title":"Biochem Pharmacol"},{"issue":"6","key":"4987_CR10","first-page":"7947","volume":"14","author":"GB Park","year":"2017","unstructured":"Park GB, Jeong JY, Kim D (2017) Ampelopsin-induced reactive oxygen species enhance the apoptosis of colon cancer cells by activating endoplasmic reticulum stress-mediated AMPK\/MAPK\/XAF1 signaling. Oncol Lett 14(6):7947\u20137956","journal-title":"Oncol Lett"},{"issue":"45","key":"4987_CR11","doi-asserted-by":"publisher","first-page":"31188","DOI":"10.1074\/jbc.M114.602961","volume":"289","author":"L Zhang","year":"2014","unstructured":"Zhang L, Niu Y, Zhu L et al (2014) Different interaction modes for protein-disulfide isomerase (PDI) as an efficient regulator and a specific substrate of endoplasmic reticulum oxidoreductin-1\u03b1 (Ero1\u03b1). J Biol Chem 289(45):31188\u201331199","journal-title":"J Biol Chem"},{"issue":"4","key":"4987_CR12","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1089\/ars.2013.5236","volume":"20","author":"L Wang","year":"2014","unstructured":"Wang L, Zhang L, Niu Y et al (2014) Glutathione peroxidase 7 utilizes hydrogen peroxide generated by Ero1\u03b1 to promote oxidative protein folding. Antioxid Redox Signal 20(4):545\u2013556","journal-title":"Antioxid Redox Signal"},{"issue":"1","key":"4987_CR13","doi-asserted-by":"publisher","first-page":"9389","DOI":"10.1038\/s41598-017-09976-7","volume":"7","author":"N Takei","year":"2017","unstructured":"Takei N, Yoneda A, Sakai-Sawada K et al (2017) Hypoxia-inducible ERO1\u03b1 promotes cancer progression through modulation of integrin-\u03b21 modification and signalling in HCT116 colorectal cancer cells [J]. Sci Rep 7(1):9389","journal-title":"Sci Rep"},{"issue":"18","key":"4987_CR14","doi-asserted-by":"publisher","first-page":"8400","DOI":"10.7150\/thno.45124","volume":"10","author":"J Zhang","year":"2020","unstructured":"Zhang J, Yang J, Lin C et al (2020) Endoplasmic reticulum stress-dependent expression of ERO1L promotes aerobic glycolysis in pancreatic cancer [J]. Theranostics 10(18):8400\u20138414","journal-title":"Theranostics"},{"issue":"5","key":"4987_CR15","first-page":"5753","volume":"16","author":"KM Kim","year":"2018","unstructured":"Kim KM, An AR, Park HS et al (2018) Combined expression of protein disulfide isomerase and endoplasmic reticulum oxidoreductin 1-\u03b1 is a poor prognostic marker for non-small cell lung cancer. Oncol Lett 16(5):5753\u20135760","journal-title":"Oncol Lett"},{"issue":"17","key":"4987_CR16","first-page":"5554","volume":"22","author":"YY Shen","year":"2018","unstructured":"Shen YY, Cui JY, Yuan J et al (2018) Mir-451a suppressed cell migration and invasion in non-small cell lung cancer through targeting ATF2. Eur Rev Med Pharmacol Sci 22(17):5554\u20135561","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"4","key":"4987_CR17","first-page":"772","volume":"50","author":"B Fan","year":"2021","unstructured":"Fan B, Jin X, Ding Q et al (2021) Expression of miR-451a in prostate cancer and its effect on prognosis. Iran J Public Health 50(4):772\u2013779","journal-title":"Iran J Public Health"},{"key":"4987_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.561763","volume":"11","author":"D Qin","year":"2021","unstructured":"Qin D, Guo Q, Wei R et al (2021) Predict colon cancer by pairing plasma miRNAs: establishment of a normalizer-free, cross-platform model. Front Oncol 11:561763","journal-title":"Front Oncol"},{"issue":"2","key":"4987_CR19","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1002\/ijc.29384","volume":"137","author":"ML Slattery","year":"2015","unstructured":"Slattery ML, Herrick JS, Mullany LE et al (2015) An evaluation and replication of miRNAs with disease stage and colorectal cancer-specific mortality. Int J Cancer 137(2):428\u2013438","journal-title":"Int J Cancer"},{"issue":"3","key":"4987_CR20","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/s41419-019-1403-x","volume":"10","author":"K Xu","year":"2019","unstructured":"Xu K, Han B, Bai Y et al (2019) MiR-451a suppressing BAP31 can inhibit proliferation and increase apoptosis through inducing ER stress in colorectal cancer [J]. Cell Death Dis 10(3):152","journal-title":"Cell Death Dis"},{"issue":"26","key":"4987_CR21","doi-asserted-by":"publisher","first-page":"39834","DOI":"10.18632\/oncotarget.9405","volume":"7","author":"JE Davis","year":"2016","unstructured":"Davis JE, Xie X, Guo J et al (2016) ARF1 promotes prostate tumorigenesis via targeting oncogenic MAPK signaling [J]. Oncotarget 7(26):39834\u201339845","journal-title":"Oncotarget"},{"issue":"5","key":"4987_CR22","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1007\/s00277-017-2949-2","volume":"96","author":"X Xu","year":"2017","unstructured":"Xu X, Wang Q, He Y et al (2017) ADP-ribosylation factor 1 (ARF1) takes part in cell proliferation and cell adhesion-mediated drug resistance (CAM-DR) [J]. Ann Hematol 96(5):847\u2013858","journal-title":"Ann Hematol"},{"issue":"10","key":"4987_CR23","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1002\/kjm2.12253","volume":"36","author":"LG Zhao","year":"2020","unstructured":"Zhao LG, Wang J, Li J et al (2020) MiR-744-5p inhibits cellular proliferation and invasion via targeting ARF1 in epithelial ovarian cancer. Kaohsiung J Med Sci 36(10):799\u2013807","journal-title":"Kaohsiung J Med Sci"},{"issue":"1","key":"4987_CR24","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1080\/21655979.2020.1863035","volume":"12","author":"J Cheng","year":"2021","unstructured":"Cheng J, Lou Y, Jiang K (2021) Downregulation of long non-coding RNA LINC00460 inhibits the proliferation, migration and invasion, and promotes apoptosis of pancreatic cancer cells via modulation of the miR-320b\/ARF1 axis [J]. Bioengineered 12(1):96\u2013107","journal-title":"Bioengineered"},{"issue":"12","key":"4987_CR25","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.202216082","volume":"14","author":"P Jin","year":"2022","unstructured":"Jin P, Jiang J, Zhou L et al (2022) Disrupting metformin adaptation of liver cancer cells by targeting the TOMM34\/ATP5B axis. EMBO Mol Med 14(12):e16082","journal-title":"EMBO Mol Med"},{"issue":"1","key":"4987_CR26","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s13046-021-01915-9","volume":"40","author":"C Li","year":"2021","unstructured":"Li C, Zhang K, Pan G et al (2021) Dehydrodiisoeugenol inhibits colorectal cancer growth by endoplasmic reticulum stress-induced autophagic pathways. J Exp Clin Cancer Res: CR 40(1):125","journal-title":"J Exp Clin Cancer Res: CR"},{"issue":"4","key":"4987_CR27","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.7150\/thno.48698","volume":"11","author":"HF Hu","year":"2021","unstructured":"Hu HF, Xu WW, Li YJ et al (2021) Anti-allergic drug azelastine suppresses colon tumorigenesis by directly targeting ARF1 to inhibit IQGAP1-ERK-Drp1-mediated mitochondrial fission [J]. Theranostics 11(4):1828\u20131844","journal-title":"Theranostics"},{"issue":"4","key":"4987_CR28","doi-asserted-by":"publisher","DOI":"10.1002\/mgg3.588","volume":"7","author":"H Yang","year":"2019","unstructured":"Yang H, Wu J, Zhang J et al (2019) Integrated bioinformatics analysis of key genes involved in progress of colon cancer. Mol Genet Genomic Med 7(4):e00588","journal-title":"Mol Genet Genomic Med"},{"issue":"2","key":"4987_CR29","doi-asserted-by":"publisher","first-page":"118","DOI":"10.15430\/JCP.2014.19.2.118","volume":"19","author":"KA Kang","year":"2014","unstructured":"Kang KA, Kim JK, Jeong YJ et al (2014) Dictyopteris undulata extract induces apoptosis via induction of endoplasmic reticulum stress in human colon cancer cells [J]. J Cancer Prev 19(2):118\u2013124","journal-title":"J Cancer Prev"},{"key":"4987_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27030920","author":"H Khan","year":"2022","unstructured":"Khan H, Alam W, Alsharif KF et al (2022) Alkaloids and colon cancer: molecular mechanisms and therapeutic implications for cell cycle arrest. Molecules. https:\/\/doi.org\/10.3390\/molecules27030920","journal-title":"Molecules"},{"issue":"20","key":"4987_CR31","doi-asserted-by":"publisher","first-page":"11073","DOI":"10.3390\/ijms222011073","volume":"22","author":"SJ Lee","year":"2021","unstructured":"Lee SJ, Lee DE, Choi SY et al (2021) OSMI-1 enhances TRAIL-induced apoptosis through ER stress and NF-\u03baB signaling in colon cancer cells. Int J Mol Sci 22(20):11073","journal-title":"Int J Mol Sci"},{"issue":"3","key":"4987_CR32","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.celrep.2015.09.016","volume":"13","author":"MCB Wielenga","year":"2015","unstructured":"Wielenga MCB, Colak S, Heijmans J et al (2015) ER-stress-induced differentiation sensitizes colon cancer stem cells to chemotherapy. Cell Rep 13(3):489\u2013494","journal-title":"Cell Rep"},{"issue":"10","key":"4987_CR33","doi-asserted-by":"publisher","first-page":"4988","DOI":"10.4049\/jimmunol.1303228","volume":"194","author":"K Kukita","year":"2015","unstructured":"Kukita K, Tamura Y, Tanaka T et al (2015) Cancer-associated oxidase ERO1-\u03b1 regulates the expression of MHC class I molecule via oxidative folding. J Immunol 194(10):4988\u20134996","journal-title":"J Immunol"},{"issue":"23","key":"4987_CR34","doi-asserted-by":"publisher","first-page":"13218","DOI":"10.1080\/07391102.2021.1984308","volume":"40","author":"H Albassam","year":"2022","unstructured":"Albassam H, Mehta CH, Nayak UY (2022) Identification of novel small molecule inhibitors for endoplasmic reticulum oxidoreductase 1\u03b1 (ERO1\u03b1) enzyme: structure-based molecular docking and molecular dynamic simulation studies [j]. J Biomol Struct Dyn 40(23):13218\u201313232","journal-title":"J Biomol Struct Dyn"},{"key":"4987_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22095016","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Wang H, Xiao H (2021) Metformin actions on the liver: protection mechanisms emerging in hepatocytes and immune cells against NASH-related HCC. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms22095016","journal-title":"Int J Mol Sci"},{"key":"4987_CR36","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s11658-017-0041-5","volume":"22","author":"M Zeng","year":"2017","unstructured":"Zeng M, Zhu L, Li L et al (2017) Mir-378 suppresses the proliferation, migration and invasion of colon cancer cells by inhibiting SDAD1 [J]. Cell Mol Biol Lett 22:12","journal-title":"Cell Mol Biol Lett"},{"key":"4987_CR37","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2021.12375","author":"Z Li","year":"2021","unstructured":"Li Z, Zhu Z, Wang Y et al (2021) Hsa-miR-15a-5p inhibits colon cell carcinoma via targeting CCND1. Mol Med Rep. https:\/\/doi.org\/10.3892\/mmr.2021.12375","journal-title":"Mol Med Rep"},{"issue":"1","key":"4987_CR38","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s13046-017-0583-4","volume":"36","author":"L Lang","year":"2017","unstructured":"Lang L, Shay C, Zhao X et al (2017) Combined targeting of Arf1 and Ras potentiates anticancer activity for prostate cancer therapeutics. J Exp Clin Cancer Res: CR 36(1):112","journal-title":"J Exp Clin Cancer Res: CR"},{"key":"4987_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/medsci10040062","author":"AA Mahbub","year":"2022","unstructured":"Mahbub AA (2022) 17\u03b2-estradiol enhances 5-fluorouracil anti-cancer activities in colon cancer cell lines. Med Sci. https:\/\/doi.org\/10.3390\/medsci10040062","journal-title":"Med Sci"},{"key":"4987_CR40","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2022.5365","author":"Q Zhao","year":"2022","unstructured":"Zhao Q, Long Y, Cheng W et al (2022) Visfatin inhibits colon cancer cell apoptosis and decreases chemosensitivity to 5-FU by promoting the SDF-1\/CXCR4\/Akt axis. Int J Oncol. https:\/\/doi.org\/10.3892\/ijo.2022.5365","journal-title":"Int J Oncol"},{"issue":"3","key":"4987_CR41","doi-asserted-by":"publisher","first-page":"265","DOI":"10.4062\/biomolther.2021.118","volume":"30","author":"MJ Piao","year":"2022","unstructured":"Piao MJ, Han X, Kang KA et al (2022) The endoplasmic reticulum stress response mediates shikonin-induced apoptosis of 5-fluorouracil-resistant colorectal cancer cells [J]. Biomol Ther 30(3):265\u2013273","journal-title":"Biomol Ther"},{"issue":"3","key":"4987_CR42","first-page":"838","volume":"10","author":"X Yao","year":"2020","unstructured":"Yao X, Tu Y, Xu Y et al (2020) Endoplasmic reticulum stress confers 5-fluorouracil resistance in breast cancer cell via the GRP78\/OCT4\/lncRNA MIAT\/AKT pathway. Am J Cancer Res 10(3):838\u2013855","journal-title":"Am J Cancer Res"},{"issue":"4","key":"4987_CR43","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.4143\/crt.2015.189","volume":"48","author":"SY Seol","year":"2016","unstructured":"Seol SY, Kim C, Lim JY et al (2016) Overexpression of endoplasmic reticulum oxidoreductin 1-\u03b1 (ERO1L) is associated with poor prognosis of gastric cancer [J]. Cancer Res Treat 48(4):1196\u20131209","journal-title":"Cancer Res Treat"}],"container-title":["International Journal of Colorectal Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00384-025-04987-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00384-025-04987-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00384-025-04987-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T17:56:33Z","timestamp":1757440593000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00384-025-04987-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,21]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4987"],"URL":"https:\/\/doi.org\/10.1007\/s00384-025-04987-7","relation":{},"ISSN":["1432-1262"],"issn-type":[{"value":"1432-1262","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,21]]},"assertion":[{"value":"8 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experimental protocols were approved by the Animal Experiment Ethics Review Committee of Kunming Medical University, and the animal procedures adhered to the ARRIVE guidelines 2.0.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"184"}}